Press release
New technology acquisition provides Unither Pharmaceuticals with specialized transmucosal paracetamol solutions
Preliminary clinical trials have shown that this technology would enable to lower the dosage of paracetamol while keeping the same effect as traditional dosage for oral forms.The deal comes after previous patents acquisitions by Unither Pharmaceuticals in the last years related to oro-dispersible formulations.
This addition will further enhance Unither Pharmaceuticals capabilities to deliver innovative solutions through its recently launched ODTechTM platform, offering several solid and liquid stick packs technologies.
Unither Pharmaceuticals’ CEO, Eric Goupil, said:
"This deal represents an important milestone for Unither Pharmaceuticals and its commitment to invest in R&D to facilitate patients’ daily life by developing affordable, convenient and easy to use products”
“It is also a significant addition to our ODTech platform, putting us in a very unique position with a multi-technology oral single dose strategy".
Unither Pharmaceuticals’ Head of Innovation & Development, Nathalie Masson, commented:
"Our clients are looking for medicines with a shorter onset of action, especially when dealing with painkillers, to deliver great experiences to their customers.
This new technology will allow us to present a truly differentiated offering, enabling us to deliver innovative solutions to patients who want a faster acting painkiller. It will also support one of the firm's strategic priorities to further embed convenience into its products."
Unither Pharmaceuticals is the global leader in sterile unit-dose contract manufacturing. We provide expertise utilizing innovative and niche technologies such as: sterile unit-dose Blow- Fill- Seal Technology (BFS), liquid stick pack, powder stick pack, oral liquids and suspensions, orodispersible solutions and extended release formulations. We produce 2.4 billion BFS doses and 260 million liquid packs annually, sold in more than 100 countries.
3-5 rue saint-georges, Paris 75009 France
unither@unither-pharma.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New technology acquisition provides Unither Pharmaceuticals with specialized transmucosal paracetamol solutions here
News-ID: 1709799 • Views: …
More Releases from Unither Pharmaceuticals
Unither Pharmaceuticals has completed the purchase of the Novartis site located …
Paris (France), 12/07/2022 - Unither Pharmaceuticals, the world's leading manufacturer of sterile unit-dose products, recently acquired the Novartis plant in São Paulo, Brazil, as a new step in its industrial expansion in Brazil.
« This acquisition enables us to benefit from sterile operations in Latin America and to enlarge our offer to multidose ophthalmic containers. We are pleased to welcome the 180 people joining Unither Pharmaceuticals and bring new possibilities to…
Unither Pharmaceuticals initiated the acquisition of Nanjing Ruinian Best Pharma …
Paris (France) and Nanjing (China), August 25th, 2020 – Unither Pharmaceuticals, a global leader in sterile single dose technology, initiated today the acquisition of Nanjing Ruinian Best Pharmaceutical Co. Ltd, a Chinese pharmaceutical company.
With this acquisition, Unither is accelerating the development of its business in China, the second largest market in the world, and complementing the worldwide Unither industrial footprint in Europe, the US and Brazil. “We are delighted…
More Releases for Pharmaceuticals’
Opioid Use Disorder Market ||Indivior, Alkermes, Titan Pharmaceuticals, Hikma Ph …
Zion Market Research published a new 110+ pages industry research “Opioid Use Disorder Market by Drug (Buprenorphine, Methadone and Naltrexone) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025” is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data…
Global Halal Pharmaceuticals Market 2019 - CCM Pharmaceuticals, Pharmaniaga, Ros …
This new report by Eon Market Research, titled “Global Halal Pharmaceuticals Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Halal Pharmaceuticals industry at a global as well as regional and country level. Key facts analyzed in this report include the Halal Pharmaceuticals market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study…
Topical Antibiotic Pharmaceuticals Market 2016-2026 | Teva Pharmaceuticals, Perr …
Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections. Skin and soft tissue infections (SSTIs) involve microbial invasion of the skin and underlying soft tissues infections are one of the most commonly occurring conditions amongst people. Most of these infections are minor and chronic in…
Lipid Disorder Treatment Market to 2017 - 2026: Teva Pharmaceuticals, Mylan Phar …
Researchmoz added Most up-to-date research on "Lipid Disorder Treatment Market - Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2026" to its huge collection of research reports
Extensive research report on global lipid disorders treatment market skilfully crafted by Transparency Market Research depicts the current as well as future scenario of various drugs used to treat lipid disorders. The research study includes analysis on key developments that are…
Halal Pharmaceuticals 2018 Global Market Key Players -CCM Pharmaceuticals, Pharm …
Halal Pharmaceuticals Market 2018
Wiseguyreports.Com Adds “Halal Pharmaceuticals – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.
Description:
In this report, the global Halal Pharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report is segmented into several key Regions,…
Global Wilson's Disease Market 2017- Valeant Pharmaceuticals International, Meda …
The Global Wilson's Disease Market 2017 Research Report includes a complete and meticulous study of Wilson's Disease industry covering different aspects like market volume, market Share, market strategies, Wilson's Disease growth trends, variety of applications, utilization volume, demand and supply analysis, production capacity and Wilson's Disease industry cost structures during Forecast period from 2017 to 2022.
The report titled Global Wilson's Disease Market 2017 provides the comprehensive study of Wilson's Disease…
